Skip to main content

Table 1 Summary of clinical characters of tongue lymphomas

From: Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV status

Case

Age (y)

Primary Site

Tumor Size (cm)

CT/MRI Findings

Clinical Symptoms

Clinical Stage

 

Treatment /modality and response

IPI score

OS (months)

1

80–85

Tongue base

3.0 cm

mass

Pharyngeal foreign body sensation

IIIA

 

R –CHOP/PR

3

97

2

70–75

Tongue base

4.6 cm

mass

Pharyngeal foreign body sensation

IVA

 

R-CHOP/NR and Progression

3

63(died)

3

75–80

Tongue base

2.0 cm

mass

Pharyngeal foreign body sensation

IVA

 

GDP + CHOP/PR

2

95

4

40–45

Tongue base

Unknown

Thicken of oropharyngeal wall and the epiglottis folds

Dysphagia, Sore throat, choking water, multi deep ulcer with Pseudomembranous

IIA

 

CHOP/CR

0

85

5

90–95

Tongue base

4.3 cm

mass

Dysphagia

IA

 

CHOP/PR

1

3 (Died)

6

45–50

Tongue base

1.5 cm

mass

Pharyngeal foreign body sensation

IA

 

CHOP/CR

0

69

7

35–40

Tongue base

2.1 cm

mass

Pharyngeal foreign body sensation, Sense of suffocation

IVA

 

R-CHOP/PR

2

40

  1. R-CHOP: R-rituximab C-cyclophosphamide H-doxorubicin (hydroxydaunomycin) O-vincristine P-prednisone; CHOP: C-cyclophosphamide H-doxorubicin (hydroxydaunomycin) O-vincristine P- prednisolone; GDP:G-gemcitabine D-dexamethasone P-ciaplatin; OS: overall survival; CR: completely response; PR: partial response